12896_2019_559_MOESM2_ESM.pptx (54.95 kB)
MOESM2 of Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
presentation
posted on 2019-10-18, 09:28 authored by Alessandro Ascione, Claudia Arenaccio, Alessandra Mallano, Michela Flego, Mara Gellini, Mauro Andreotti, Craig Fenwick, Giuseppe Pantaleo, Stefano Vella, Maurizio FedericoAdditional file 2: Figure S7AII. The treatment with the divalent scFvF7-Fc Ab increases the activation of peptide-stimulated Nef-specific CD8+ T lymphocytes in terms of IFN-Îł secretion (Exp. I and Exp. III). For details see Legend of Fig. 7a. (PPTX 40 kb)
